- Home
- WIA vs SENS Comparison
WIA vs SENS Comparison
Compare WIA & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- SENS
- Stock Information
- Founded
- WIA 2003
- SENS 1996
- Country
- WIA United States
- SENS United States
- Employees
- WIA N/A
- SENS N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- SENS Industrial Machinery/Components
- Sector
- WIA Finance
- SENS Industrials
- Exchange
- WIA Nasdaq
- SENS Nasdaq
- Market Cap
- WIA 186.8M
- SENS 619.1M
- IPO Year
- WIA N/A
- SENS N/A
- Fundamental
- Price
- WIA $8.26
- SENS $0.93
- Analyst Decision
- WIA
- SENS Strong Buy
- Analyst Count
- WIA 0
- SENS 1
- Target Price
- WIA N/A
- SENS $2.00
- AVG Volume (30 Days)
- WIA 39.2K
- SENS 20.3M
- Earning Date
- WIA 01-01-0001
- SENS 02-27-2025
- Dividend Yield
- WIA 12.29%
- SENS N/A
- EPS Growth
- WIA N/A
- SENS N/A
- EPS
- WIA N/A
- SENS N/A
- Revenue
- WIA N/A
- SENS $22,205,000.00
- Revenue This Year
- WIA N/A
- SENS $0.43
- Revenue Next Year
- WIA N/A
- SENS $60.55
- P/E Ratio
- WIA N/A
- SENS N/A
- Revenue Growth
- WIA N/A
- SENS 11.41
- 52 Week Low
- WIA $7.56
- SENS $0.25
- 52 Week High
- WIA $8.91
- SENS $1.20
- Technical
- Relative Strength Index (RSI)
- WIA 59.46
- SENS 56.43
- Support Level
- WIA $8.09
- SENS $0.79
- Resistance Level
- WIA $8.21
- SENS $0.95
- Average True Range (ATR)
- WIA 0.09
- SENS 0.12
- MACD
- WIA 0.02
- SENS -0.02
- Stochastic Oscillator
- WIA 73.33
- SENS 42.02
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.